EUVIMEDEUVIMED entdecken
Crossref

Chinese expert consensus on the combined use of antiviral drugs for novel coronavirus infection

Guangbin Chen, Jing Yuan, Yue Wei, Yanfen Wu, Qian Zhang, Xinru Li, Liang Fu, Yuan Gao, Yourou Zheng, Haixia Sun, Weizhen Weng, Jun Chen und 34 weitere

BioScience Trends · 2025

DOI: 10.5582/bst.2025.01244 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioScience Trends, 2025. Verfasst von Guangbin Chen und 45 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Third People's Hospital of Shenzhen, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Antiviral Agents, COVID-19 Drug Treatment. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsCOVID-19 Drug TreatmentHumansSARS-CoV-2ChinaDrug Therapy, CombinationRitonavirConsensusCOVID-19East Asian People

Stichwörter der Autor:innen

COVID-19antiviral therapydrug combinationexpert consensusnovel coronavirus infectionsmall molecule drugs

Substanzen

Antiviral AgentsRitonavir

Autor:innen und Institutionen

  • Department of Pharmacy, The Third People's Hospital of Shenzhen, Shenzhen, Guangdong, China.
  • Department of Infectious Diseases, The Third People's Hospital of Shenzhen, Shenzhen, Guangdong, China.
  • Guangdong Medical University, Dongguan Campus, Dongguan, Guangdong, China.
  • Shenzhen Hospital of Beijing University of Chinese Medicine (Longgang) Shenzhen, Shenzhen, Guangdong, China.
  • National Center for Infectious Disease Research, The Third People's Hospital of Shenzhen, Shenzhen, Guangdong, China.
  • Department of Tuberculosis, The Third People's Hospital of Shenzhen, Shenzhen, Guangdong, China.

Zitieren

APA

Chen, G., Yuan, J., Wei, Y., Wu, Y., Zhang, Q., Li, X., Fu, L., Gao, Y., Zheng, Y., Sun, H., Weng, W., Chen, J., Chong, Y., Wu, T., Wu, G., Gong, Z., Deng, X., Mao, L., Huang, C., …, & National Medical Research Center for Infectious Diseases (2025). Chinese expert consensus on the combined use of antiviral drugs for novel coronavirus infection. BioScience Trends. https://doi.org/10.5582/bst.2025.01244

Vancouver

Chen G, Yuan J, Wei Y, Wu Y, Zhang Q, Li X, et al. Chinese expert consensus on the combined use of antiviral drugs for novel coronavirus infection. BioScience Trends. 2025. doi:10.5582/bst.2025.01244

BibTeX
@article{Chen2025,
  author = {Chen, Guangbin and Yuan, Jing and Wei, Yue and Wu, Yanfen and Zhang, Qian and Li, Xinru and Fu, Liang and Gao, Yuan and Zheng, Yourou and Sun, Haixia and Weng, Weizhen and Chen, Jun and Chong, Yutian and Wu, Tao and Wu, Gang and Gong, Zuojiong and Deng, Xilong and Mao, Lin and Huang, Chenghui and Qu, Zhijun and Qin, Bo and Jiang, Yongfang and Lin, Feng and Lin, Bingliang and Liu, Xi and Xu, Kaijin and Peng, Jie and Wu, Zhuguo and Liu, Chunsha and Li, Wen and Qiao, Kun and Yang, Liuqing and Ye, Chunxin and Huang, Jia and Xu, Yana and Zhang, Junhao and Sun, Yehong and Lai, Xiaomei and Liu, Bin and Qian, Wenjing and Li, Xiongfang and Yu, HaiLin and Yang, Xiaojuan and Hu, Zhongjie and Lu, Hongzhou and National Medical Research Center for Infectious Diseases, National Medical Research Center for Infectious Diseases},
  title = {Chinese expert consensus on the combined use of antiviral drugs for novel coronavirus infection},
  journal = {BioScience Trends},
  year = {2025},
  doi = {10.5582/bst.2025.01244}
}
Kostenlos starten →